Ki-67 and Bcl-2 antigen expression in adenomatous colorectal polyps from women with breast cancer

Annals of Surgical Oncology

Volumn 17, Issue 9, 2010, Pages 2378-2383

  De Sousa Júnior, Edílson Carvalho ^a   Alencar, Airlane Pereira ^b   Da Silva, Benedito Borges ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2;

ADENOMATOUS POLYP; ADULT; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; COLON POLYP; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY;

ADENOMATOUS POLYPOSIS COLI; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLON; COLONOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECTUM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77956338992     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0968-5     Document Type: Article

References (34)

1. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 533 543 10.1016/S1470-2045(01)00486-7 11905707
2. M Sant R Capocaccia MP Coleman, et al. 2001 Cancer survival increases in Europe, but international differences remain wide Eur J Cancer 37 1659 1667 10.1016/S0959-8049(01)00206-4 11527693
3. LX Clegg FP Li BF Hankey, et al. 2002 Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study Arch Intern Med 162 1985 1993 10.1001/archinte.162.17. 1985 12230422
4. S Khalil F Ceccarelli 2009 Colorectal cancer after breast cancer: magnitude of risk in clinical practice and in the literature Tumori 95 28 31 19366052
5. A Trentham-Dietz PA Newcomb HB Nichols JM Hampton 2007 Breast cancer risk factors and second primary malignancies among women with breast cancer Breast Cancer Res Treat 105 195 207 10.1007/s10549-006-9446-y 17186360
6. T Ochsenkühn E Bayerdörffer A Meining, et al. 2005 Increased prevalence of colorectal adenomas in women with breast cancer Digestion 72 150 155 10.1159/000088370 16172552
7. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 759 767 10.1016/0092-8674(90)90186-I 2188735
8. B Vogelstein ER Fearon SR Hamilton, et al. 1988 Genetic alterations during colorectal-tumor development N Engl J Med 319 525 532 10.1056/NEJM198809013190901 2841597
9. AH Wyllie 1985 The biology of cell death in tumours Anticancer Res 5 131 136 2986519
10. Y Kikuchi WN Dinjens FT Bosman 1997 Proliferation and apoptosis in proliferative lesions of the colon and rectum Virchows Arch 431 111 117 10.1007/s004280050076 9293892
11. P Rozen Z Fireman N Fine, et al. 1990 Rectal epithelial proliferation in women recovered from breast cancer Cancer Lett 55 189 194 10.1016/0304-3835(90) 90118-H 2257537
12. HJ van Slooten PC Clahsen JH van Dierendonck, et al. 1996 Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy Br J Cancer 74 78 85 8679463
13. Bussab W, Morettin PA. Estatística Básica. São Paulo: Editora Saraiva; 2002.
14. Agresti A. Categorical data analysis. 2nd ed. New York: Wiley; 2002.
15. Conover WJ. Practical nonparametric statistics. 2nd ed. New York: Wiley; 1980.
16. McCullagh P, Nelder JA. Generalized linear models. 2nd ed. London: Chapman & Hall; 1989.
17. SJ Stryker BG Wolff CE Culp, et al. 1987 Natural history of untreated colonic polyps Gastroenterology 93 1009 1013 3653628
18. LC Thygesen M Grønbaek C Johansen, et al. 2008 Prospective weight change and colon cancer risk in male US health professionals Int J Cancer 123 1160 1165 10.1002/ijc.23612 18546286
19. F Konishi BC Morson 1982 Pathology of colorectal adenomas: a colonoscopic survey J Clin Pathol 35 830 841 10.1136/jcp.35.8.830 7107955
20. PG Johnston MJ O'Brien PA Dervan, et al. 1989 Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa Hum Pathol 20 696 700 10.1016/0046-8177(89)90158-5 2661411
21. BA Stoll 1998 Association between breast and colorectal cancers Br J Surg 85 1468 1472 10.1046/j.1365-2168.1998.00921.x 9823904
22. HF Vasen 2007 The Lynch syndrome (hereditary nonpolyposis colorectal cancer) (review) Aliment Pharmacol Ther 26 113 126 10.1111/j.1365-2036.2007. 03479.x 18081655
23. D Ford DF Easton DT Bishop, et al. 1994 Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Lancet 343 692 695 10.1016/S0140-6736(94)91578-4 7907678
24. S Kozuka 1975 Premalignancy of the mucosal polyp in the large intestine: I. Histologic gradation of the polyp on the basis of epithelial pseudostratification and glandular branching Dis Colon Rectum 18 483 493 10.1007/BF02587217 1181150
25. R Vernillo B Lorenzi T Banducci, et al. 2008 Immunohistochemical expression of p53 and Ki67 in colorectal adenomas and prediction of malignancy and development of new polyps Int J Biol Markers 23 89 95 18629781
26. M Risio S Coverlizza A Ferrari, et al. 1988 Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel Gastroenterology 94 899 906 3345890
27. M Lipkin 1974 Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer Cancer 34 Suppl 878 888 10.1002/1097-0142(197409)34:3+<878::AID-CNCR2820340715>3.0.CO;2-R 4853616
28. NJ Carr JM Monihan UC Nzeako, et al. 1995 Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large intestine J Clin Pathol 48 46 52 10.1136/jcp.48.1.46 7706518
29. J Gerdes H Lemke H Baisch, et al. 1984 Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1710 1715 6206131
30. BB da Silva IM Lopes LH Gebrim 2006 Effects of raloxifene on normal breast tissue from premenopausal women Breast Cancer Res Treat 95 99 103 10.1007/s10549-005-9001-2 16205837
31. BB da Silva CG Pires AR Dos Santos, et al. 2009 Effects of raloxifene on Ki-67 and CD34 antigen expression in breast cancer Gynecol Obstet Invest 67 103 108 10.1159/000165512 18953168
32. S Krajewski S Tanaka S Takayama, et al. 1993 Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes Cancer Res 53 4701 4714 8402648
33. LG dos Santos PV Lopes-Costa AR dos Santos, et al. 2008 Bcl-2 oncogene expression in estrogen receptorpositive and-negative breast carcinoma Eur J Gynaecol Oncol 29 459 461 19051812
34. Y Tsujimoto CM Croce 1986 Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma Proc Natl Acad Sci U S A 83 5214 5218 10.1073/pnas.83.14.5214 3523487